OpenBilldrug price receipt

NADAC week of 2026-10-14

KETOROLAC 0.4% OPHTH SOLUTION

For 5 mL

Pharmacies pay

$63.37 filed

5 × $12.67371 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$77.88 estimated

$63.37 + $9.51 (15%) + $5.00 fee per fill = $77.88

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

KETOROLAC 0.4% OPHTH SOLUTION is how the CMS NADAC file names this product. The FDA NDC Directory lists it as ketorolac tromethamine.

FDA gives its dosage form as solution/ drops and its route as ophthalmic.

The labeler, the company named on the label, is Pacific Pharma, Inc.

FDA lists it under 2 Established Pharmacologic Classes: Cyclooxygenase Inhibitor and Nonsteroidal Anti-inflammatory Drug.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 60758-0773-05.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $63.37 for 5 mL (5 × $12.67371 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The NDC

Other strengths, forms and brands

5 other products in the NADAC file share the FDA nonproprietary name ketorolac tromethamine with KETOROLAC 0.4% OPHTH SOLUTION.

ProductPharmacies pay per unitMedicare per unit
ACULAR LS 0.4% OPHTH SOL
brand · solution/ drops
$54.455 per ML filed
eff. 2026-09-23
We don’t know yet
KETOROLAC 0.4% OPHTH SOLUTION this page
generic · solution/ drops
$12.67371 per ML filed
eff. 2026-09-23
We don’t know yet
KETOROLAC 0.5% OPHTH SOLUTION
generic · solution / solution/ drops
$1.33836 to $1.45085 per ML filed
eff. 2026-09-23
We don’t know yet
KETOROLAC 10 MG TABLET
generic · tablet, film coated / tablet
$0.16448 per EA filed
eff. 2026-09-23
We don’t know yet
KETOROLAC 30 MG/ML VIAL
generic · injection, solution / injection
$1.01747 per ML filed
eff. 2026-09-23
$1.138 per ML derived
Part B limit 2026 Q4
KETOROLAC 60 MG/2 ML VIAL
generic · injection, solution / injection
$0.55237 per ML filed
eff. 2026-09-23
$1.138 per ML derived
Part B limit 2026 Q4

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Compared with its class

Its NADAC price is $12.67371 per ML filed.

Of the 4 other products in FDA’s Cyclooxygenase Inhibitor class priced per ML, 1 has a higher middle NADAC price and 3 a lower one. The one in the middle is KETOROLAC 30 MG/ML VIAL, at $1.01747 per ML filed (eff. 2026-09-23).

Of the 25 other products in FDA’s Nonsteroidal Anti-inflammatory Drug class priced per ML, 9 have a higher middle NADAC price and 16 a lower one. The one in the middle is KETOROLAC 30 MG/ML VIAL, at $1.01747 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 5 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 5 mL in one package for this product’s NDC (“1 BOTTLE, DROPPER in 1 CARTON (60758-773-05) / 5 mL in 1 BOTTLE, DROPPER”), so the card starts at one package: 5 ML. Change it to match your prescription.